mesenchymal stem cells (Ocata)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemesenchymal stem cells (Ocata)
Drug Alias Namemesenchymal stem cells (Astellas)mesenchymal stem cells (Advanced Cell Technology)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Institute For Regenerative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Institute For Regenerative Medicine
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A